The number and frequency of intravesical instillations for non-muscle-invasive bladder cancer (NMIBC) impairs quality of life and needs to be reported in clinical trials.

A research team at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) has developed a radiopharmaceutical molecule marker that ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

NEW YORK — Alpenglow Biosciences has partnered with digital pathology lab PathNet to develop 3D pathology-based diagnostics for prostate and bladder cancers, the companies said on Thursday.

Alpenglow Biosciences, the leader in clinical-grade 3D digital pathology and AI-powered spatial analytics, and PathNet, one of the nation’s foremost pathology laboratories and largest ...

Dr Anna Wilkins’ group is investigating how to target the tumour microenvironment of bladder and prostate cancer to prevent treatment resistance, especially to radiation given with curative intent.

CorePlus announced the implementation of AIxURO, a state-of-the-art software solution that utilizes artificial intelligence ...

Abstract: Accurately predicting the impact of hormonal therapy on Prostate Cancer (PC) lesions is paramount for effective treatment planning and monitoring. This study proposes a comprehensive ...

While the current approval focuses on the second-line setting, research is already moving into earlier stages of the ...

Investigators studied US trends in the diagnosis of variant histology bladder cancer using the National Cancer database.

NEW YORK – Oncology diagnostics firm Valar Labs said Monday it has formed a strategic partnership with pathology lab PathNet Lab. The deal gives clinicians in Little Rock, Arkansas-based PathNet's ...

Valar Labs, a leader in AI-powered diagnostics for oncology, today announced a strategic partnership with PathNet Lab, one of the nation’s foremost pathology laboratories. Through this collaboration, ...